Short-term effects of the smoke-free legislation on haemostasis and systemic inflammation due to second hand smoke exposure

Thrombosis and Haemostasis

Volumn 105, Issue 6, 2011, Pages 1024-1031

  Cayla, Guillaume ^a   Sie, Pierre ^b   Silvain, Johanne ^a   Brugier, Delphine ^a   Cambou, Jean Pierre ^c   Thomas, Daniel ^a   Pena, Ana ^a   O'Connor, Stephen A ^a   Bura, Alessandra ^c   Ruidavets, Jean Bernard ^c   Montalescot, Gilles ^a   Collet, Jean Philippe ^a  

^a PITIÉ SALPÊTRIÈRE HOSPITAL   (France)

^b INSERM   (France)

^c UNIVERSITÉ DE TOULOUSE   (France)

Author keywords

Fibrin clot; Inflammatory biomarkers; Platelet reactivity; Second hand smoke; Smoke free legislation

Indexed keywords

BIOLOGICAL MARKER; C REACTIVE PROTEIN; COTININE; D DIMER; FIBRIN; FIBRINOGEN; INTERLEUKIN 6; PLASMINOGEN ACTIVATOR INHIBITOR 1; TUMOR NECROSIS FACTOR ALPHA; VON WILLEBRAND FACTOR;

ADULT; AGE; ARTERIAL STIFFNESS; ARTICLE; BLOOD CLOT LYSIS; BLOOD CLOTTING; BLOOD CLOTTING TIME; CLINICAL TRIAL; CONTROLLED STUDY; ENVIRONMENTAL EXPOSURE; FEMALE; FIBRINOLYSIS; GENDER; HEMOSTASIS; HUMAN; HUMAN EXPERIMENT; INFLAMMATION; LAW; MALE; NORMAL HUMAN; OCCUPATIONAL EXPOSURE; PASSIVE SMOKING; PRIORITY JOURNAL; PROSPECTIVE STUDY; SMOKING CESSATION PROGRAM; THROMBOCYTE RELEASE REACTION; THROMBOSIS; URINE LEVEL;

ACUTE CORONARY SYNDROME; BIOLOGICAL MARKERS; CLOT RETRACTION; FIBRINOLYSIS; FRANCE; HEMOSTASIS; HUMANS; INCIDENCE; INFLAMMATION; LEGISLATION AS TOPIC; OCCUPATIONAL EXPOSURE; PLATELET ACTIVATION; TOBACCO SMOKE POLLUTION;

EID: 79958141411     PISSN: 03406245     EISSN: None     Source Type: Journal    
DOI: 10.1160/TH11-02-0062     Document Type: Article

References (31)

1. Jonas MA, et al. Statement on smoking and cardiovascular disease for health care professionals. American Heart Association. Circulation 1992; 86: 1664-1669.
2. Ambrose JA, Barua RS. The pathophysiology of cigarette smoking and cardiovascular disease: an update. J Am Coll Cardiol 2004; 43: 1731-1737.
3. Barua RS, et al. Reactive oxygen species are involved in smoking-induced dysfunction of nitric oxide biosynthesis and upregulation of endothelial nitric oxide synthase: an in vitro demonstration in human coronary artery endothelial cells. Circulation 2003; 107: 2342-2347.
4. Barnoya J, Glantz SA. Cardiovascular effects of secondhand smoke: nearly as large as smoking. Circulation 2005; 111: 2684-2698.
5. Teo KK, et al. Tobacco use and risk of myocardial infarction in 52 countries in the INTERHEART study: a case-control study. Lancet 2006; 368: 647-658.
6. Oberg M, et al. Worldwide burden of disease from exposure to second-hand smoke: a retrospective analysis of data from 192 countries. Lancet 2011; 377: 139-146.
7. Lightwood JM, Glantz SA. Declines in acute myocardial infarction after smokefree laws and individual risk attributable to secondhand smoke. Circulation 2009; 120: 1373-1379.
8. Mackay DF, et al. Meta-analysis of the effect of comprehensive smoke-free legislation on acute coronary events. Heart 2010; 96: 1525-1530.
9. Collet JP, et al. Altered fibrin architecture is associated with hypofibrinolysis and premature coronary atherothrombosis. Arterioscler Thromb Vasc Biol 2006; 26: 2567-2573.
10. Barua RS, et al. Effects of cigarette smoke exposure on clot dynamics and fibrin structure: an ex vivo investigation. Arterioscler Thromb Vasc Biol 2010; 30: 75-79.
11. Rop PP, et al. Determination of nicotine and its main metabolites in urine by highperformance liquid chromatography. J Chromatogr 1993; 612: 302-309.
12. Verbeke M. Linear Mixed Models for Longitudinal Data. 2nd ed New York: Springer-Verlag. 2001.
13. Sims M, et al. Short term impact of smoke-free legislation in England: retrospective analysis of hospital admissions for myocardial infarction. Br Med J 2010; 340: c2161.
14. Scott EM, et al. Genetic and Environmental Determinants of Fibrin Structure and Function Relevance to Clinical Disease. Atheroscler Thromb Vasc Biol 2004; 24: 1558-1566.
15. Collet JP, et al. Influence of fibrin network conformation and fibrin fiber diameter on fibrinolysis speed: dynamic and structural approaches by confocal microscopy. Arterioscler Thromb Vasc Biol 2000; 20: 1354-1361.
16. Undas A, et al. Fibrin clot properties are altered in patients with chronic obstructive pulmonary disease. Beneficial effects of simvastatin treatment. Thromb Haemost 2009; 102: 1176-1182.
17. Mills JD, et al. Altered fibrin clot structure in the healthy relatives of patients with premature coronary artery disease. Circulation 2002; 106: 1938-1942.
18. Morita H, et al. Only two-week smoking cessation improves platelet aggregability and intraplatelet redox imbalance of long-term smokers. J Am Coll Cardiol 2005; 45: 589-594.
19. Takajo Y, et al. Augmented oxidative stress of platelets in chronic smokers. Mechanisms of impaired platelet-derived nitric oxide bioactivity and augmented platelet aggregability. J Am Coll Cardiol 2001; 38: 1320-1327.
20. Fusegawa Y, Handa S. Platelet aggregation induced by ADP or epinephrine is enhanced in habitual smokers. Thromb Res 2000; 97: 287-295.
21. Rubenstein D, et al. Differences between mainstream and sidestream cigarette smoke extracts and nicotine in the activation of platelets under static and flow conditions. Circulation 2004; 109: 78-83.
22. Undas A, et al. Statins, fenofibrate, and quinapril increase clot permeability and enhance fibrinolysis in patients with coronary artery disease. J Thromb Haemost 2006; 4: 1029-1036.
23. Blache D. Involvement of hydrogen and lipid peroxides in acute tobacco smokinginduced platelet hyperactivity. Am J Physiol 1995; 268: H679-685.
24. Fusegawa Y, et al. Platelet spontaneous aggregation in platelet-rich plasma is increased in habitual smokers. Thromb Res 1999; 93: 271-278.
25. Roitman EV, et al. Oxidatively modified fibrinogen modulates blood rheological parameters. Bull Exp Biol Med 2004; 138: 467-469.
26. Tetik S, et al. Oxidative modification of fibrinogen affects its binding activity to glycoprotein (GP) IIb/IIIa. Clin Appl Thromb Hemost 2010; 16: 51-59.
27. Venn A, Britton J. Exposure to secondhand smoke and biomarkers of cardiovascular disease risk in never-smoking adults. Circulation 2007; 115: 990-995.
28. Jefferis BJ, et al. Secondhand smoke (SHS) exposure is associated with circulating markers of inflammation and endothelial function in adult men and women. Atherosclerosis 2010; 208: 550-556.
29. Yanbaeva DG, et al. Systemic effects of smoking. Chest 2007; 131: 1557-1566.
30. Rudez G, et al. Biological variation in inflammatory and hemostatic markers. J Thromb Haemost 2009; 7: 1247-1255.
31. Bura A, et al. Impact of smoking prohibition in bars, restaurants and discotheques on employees endothelial function: the DILATER study. European Heart J 2009; Suppl.: Abstract 584.